Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

March 31, 2000

Primary Completion Date

August 31, 2003

Study Completion Date

August 31, 2003

Conditions
Alzheimer Disease
Interventions
DRUG

aripiprazole

Trial Locations (41)

Unknown

Local Institution, Tuscaloosa

Local Institution, Scottsdale

Local Institution, Cerritos

Local Institution, Granada Hills

Local Institution, Los Angeles

Local Institution, San Diego

Local Institution, Torrance

Local Institution, Denver

Local Institution, Hamden

Local Institution, Miami

Local Institution, North Miami Beach

Local Institution, West Palm Beach

Local Institution, Atlanta

Local Institution, Augusta

Local Institution, Macon

Local Institution, Honolulu

Local Institution, North Chicago

Local Institution, Springfield

Local Institution, New Orleans

Local Institution, Shreveport

Local Institution, Baltimore

Local Institution, Newton Center

Local Institution, Springfield

Local Institution, Wellesley Hills

Local Institution, Lyons

Local Institution, Albany

Local Institution, Lawrence

Local Institution, Montrose

Local Institution, Northport

Local Institution, White Plains

Local Institution, Raleigh

Local Institution, Beachwood

Local Institution, Portland

Local Institution, Hershey

Local Institution, Austin

Local Institution, Dallas

Local Institution, San Antonio

Local Institution, Wichita Falls

Local Institution, Bennington

Local Institution, Charlottesville

Local Institution, Seattle

All Listed Sponsors
lead

Otsuka Pharmaceutical Development & Commercialization, Inc.

INDUSTRY

NCT00036114 - Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type | Biotech Hunter | Biotech Hunter